Icon

CORGARD (nda018063)- (20MG,40MG,80MG,120MG,160MG)

NADOLOL USWM
20MG,40MG,80MG,120MG,160MG
No No
Expired Expired
None None
None No
CORGARD (nadolol) is indicated for the long-term management of patients with angina pectoris. CORGARD (nadolol) is indicated for the treatment of hypertension, to lower blood pressure. CORGARD (nadolol) may be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics.
12 0 11
Total Other Developers 4
Drugs with Suitability No
20MG ** ** - - 7
40MG ** ** - - 7
80MG ** ** - 5 2
120MG ** ** - - -
160MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 10
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ***** *************** ***. *********** **** ******* ***** ****, **********, **** ******** (**) *****, ****** ****** (***) ***
****** ******** ****** ******* ************ ******* *********** *** ****-* **** **. *-**/*, *-***, & *-***, **** **. **, *** ********, ***** ******, *******-**********, ********* ******, ***** (***) ***
****** ******* ****** ******* ***************, *** *********** * **** ***., *********, *** **** (**) *****, ****** ****** (***) ***
****** ***** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ****** ****** ** ****** *************** ******* ******* *********** **** ** ** & **, ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***.: ******, *********, ** ******, ***** (***) ***
****** ******* ****** *** ******* *************** ******* *********** ***, *********, *****, ******* ****, ********** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, **. **.*** & ***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***
****** ******* ******* *************** ******* *********** *********** ********, ******* *******, *.*. *******, **** *****, ****** *****,, **********, ******* ******, ***** (***) ***
****** ******** ****** ******* ************ ******* *********** *** ****-* **** **. *-**/*, *-***, & *-***, **** **. **, *** ********, ***** ******, *******-**********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.